Cargando…
HDAC2 Facilitates Pancreatic Cancer Metastasis
The mortality of patients with pancreatic ductal adenocarcinoma (PDAC) is strongly associated with metastasis, a multistep process that is incompletely understood in this disease. Although genetic drivers of PDAC metastasis have not been defined, transcriptional and epigenetic rewiring can contribut...
Autores principales: | Krauß, Lukas, Urban, Bettina C., Hastreiter, Sieglinde, Schneider, Carolin, Wenzel, Patrick, Hassan, Zonera, Wirth, Matthias, Lankes, Katharina, Terrasi, Andrea, Klement, Christine, Cernilogar, Filippo M., Öllinger, Rupert, de Andrade Krätzig, Niklas, Engleitner, Thomas, Schmid, Roland M., Steiger, Katja, Rad, Roland, Krämer, Oliver H., Reichert, Maximilian, Schotta, Gunnar, Saur, Dieter, Schneider, Günter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359718/ https://www.ncbi.nlm.nih.gov/pubmed/34903606 http://dx.doi.org/10.1158/0008-5472.CAN-20-3209 |
Ejemplares similares
-
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
por: Lankes, Katharina, et al.
Publicado: (2020) -
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition
por: Schneeweis, Christian, et al.
Publicado: (2022) -
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
por: Schneeweis, Christian, et al.
Publicado: (2022) -
Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype
por: Orben, Felix, et al.
Publicado: (2022) -
Mir34a constrains pancreatic carcinogenesis
por: Hidalgo-Sastre, Ana, et al.
Publicado: (2020)